de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Poster

Assessment of the protective effect of L-Carnitine in Hepatic Encephalopathy: Improvements of muscle and brain mitochondrial and fatty acid metabolism

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons83941

Gottschalk,  S
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Zwingmann, C., Gottschalk, S., Wenlei J, Butterworth, R., & Leibfritz, D. (2007). Assessment of the protective effect of L-Carnitine in Hepatic Encephalopathy: Improvements of muscle and brain mitochondrial and fatty acid metabolism. Poster presented at 2007 Joint Annual Meeting ISMRM-ESMRMB, Berlin, Germany.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-CDCF-D
Zusammenfassung
Hepatic Encephalopathy (HE) in both chronic and acute liver failure is associated with hyperammonemia and energetic changes in brain and peripheral organs. In animal models and in patients with mild HE, L-carnitine has been shown to be protective. In order to investigate the effect of L-carnitine on energy- and fatty acid metabolism, 1H- and 13C-NMR spectroscopy was used to measure metabolic pathways in brain and muscle following administration of [U-13C]glucose to rats with mild HE and in rats with ammonia-precipitated encephalopathy. Portacaval anastomosis in the rat resulted in a broad spectrum of neurobehavioral changes, such as a 80 impaired locomotor activity, which was largely prevented by L-carnitine. Concomitantly, L-carnitine improved mitochondrial energy metabolism and fatty acid catabolism in brain and muscle. In ammonia-precipitated encephalopathy, L-carnitine considerably delayed the time to coma of the rats, concomitantly to a prevention of ammonia-induced increased lactate synthesis in the brain. These results demonstrate that L-carnitine acts both in the brain and in the muscle by improvement of mitochondrial metabolism and fatty acid catabolism, which might explain L-carnitine’s therapeutic benefit in the prevention of mild HE and ammonia-precipitated encephalopathy in cirrhotic patients.